Baird Financial Group’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-40,142
Closed -$3.58M 1278
2017
Q1
$3.58M Sell
40,142
-184,667
-82% -$15.2M 0.03% 467
2016
Q4
$15.9M Buy
224,809
+221,379
+6,454% +$16.5M 0.14% 175
2016
Q3
$271K Sell
3,430
-58
-2% -$4.95K ﹤0.01% 1077
2016
Q2
$317K Sell
3,488
-1,127
-24% -$95.4K ﹤0.01% 1038
2016
Q1
$393K Sell
4,615
-255,419
-98% -$19M ﹤0.01% 981
2015
Q4
$20.5M Sell
260,034
-6,591
-2% -$519K 0.21% 141
2015
Q3
$18.8M Sell
266,625
-2,583
-1% -$212K 0.2% 142
2015
Q2
$24.3M Buy
+269,208
New +$26M 0.24% 127

Other funds holding MJN

Baird Financial Group's MJN Position: Q2 2017 in Review

Baird Financial Group sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 40,142 shares — an estimated $3.58M sold.

Baird Financial Group first reported a position in MJN in Q2 2015 and held it in 8 quarters. The position peaked at $24.3M in Q2 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Baird Financial Group reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Baird Financial Group sold 40,142 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $3.58M.
  • Baird Financial Group first reported a position in Mead Johnson Nutrition Company in Q2 2015 and held it in 8 quarters.
  • Baird Financial Group's Mead Johnson Nutrition Company position peaked at $24.3M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Baird Financial Group's 13F filing for Q2 2017, filed 14 Aug 2017.